Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 644

1.

Longitudinal analysis of risk factors for dementia based on Mild Cognitive Impairment Screen results and questionnaire responses from healthy Japanese individuals registered in an online database.

Ogawa M, Maruo K, Sone D, Shimada H, Suzuki K, Watanabe H, Matsuda H, Mizusawa H.

Alzheimers Dement (N Y). 2019 Aug 2;5:347-353. doi: 10.1016/j.trci.2019.06.003. eCollection 2019.

2.

Ataxic phenotype with altered CaV3.1 channel property in a mouse model for spinocerebellar ataxia 42.

Hashiguchi S, Doi H, Kunii M, Nakamura Y, Shimuta M, Suzuki E, Koyano S, Okubo M, Kishida H, Shiina M, Ogata K, Hirashima F, Inoue Y, Kubota S, Hayashi N, Nakamura H, Takahashi K, Katsumoto A, Tada M, Tanaka K, Sasaoka T, Miyatake S, Miyake N, Saitsu H, Sato N, Ozaki K, Ohta K, Yokota T, Mizusawa H, Mitsui J, Ishiura H, Yoshimura J, Morishita S, Tsuji S, Takeuchi H, Ishikawa K, Matsumoto N, Ishikawa T, Tanaka F.

Neurobiol Dis. 2019 Oct;130:104516. doi: 10.1016/j.nbd.2019.104516. Epub 2019 Jun 20.

PMID:
31229688
3.

Tyrosol Reduces Amyloid-β Oligomer Neurotoxicity and Alleviates Synaptic, Oxidative, and Cognitive Disturbances in Alzheimer's Disease Model Mice.

Taniguchi K, Yamamoto F, Arai T, Yang J, Sakai Y, Itoh M, Mamada N, Sekiguchi M, Yamada D, Saitoh A, Kametani F, Tamaoka A, Araki YM, Wada K, Mizusawa H, Araki W.

J Alzheimers Dis. 2019;70(3):937-952. doi: 10.3233/JAD-190098.

PMID:
31227651
4.

Age at onset in genetic prion disease and the design of preventive clinical trials.

Minikel EV, Vallabh SM, Orseth MC, Brandel JP, Haïk S, Laplanche JL, Zerr I, Parchi P, Capellari S, Safar J, Kenny J, Fong JC, Takada LT, Ponto C, Hermann P, Knipper T, Stehmann C, Kitamoto T, Ae R, Hamaguchi T, Sanjo N, Tsukamoto T, Mizusawa H, Collins SJ, Chiesa R, Roiter I, de Pedro-Cuesta J, Calero M, Geschwind MD, Yamada M, Nakamura Y, Mead S.

Neurology. 2019 Jul 9;93(2):e125-e134. doi: 10.1212/WNL.0000000000007745. Epub 2019 Jun 6.

PMID:
31171647
5.

Prevalence and clinicoradiological features of spinocerebellar ataxia type 34 in a Japanese ataxia cohort.

Ozaki K, Ansai A, Nobuhara K, Araki T, Kubodera T, Ishii T, Higashi M, Sato N, Soga K, Mizusawa H, Ishikawa K, Yokota T.

Parkinsonism Relat Disord. 2019 May 13. pii: S1353-8020(19)30241-X. doi: 10.1016/j.parkreldis.2019.05.019. [Epub ahead of print]

PMID:
31105016
6.

Specific amyloid-β42 deposition in the brain of a Gerstmann-Sträussler-Scheinker disease patient with a P105L mutation on the prion protein gene.

Furukawa F, Sanjo N, Kobayashi A, Hamaguchi T, Yamada M, Kitamoto T, Mizusawa H, Yokota T.

Prion. 2018;12(5-6):315-319. doi: 10.1080/19336896.2018.1541689. Epub 2018 Nov 13.

PMID:
30394185
7.

Clinical features of the behavioural variant of frontotemporal dementia that are useful for predicting underlying pathological subtypes of frontotemporal lobar degeneration.

Kobayashi Z, Arai T, Kawakami I, Yokota O, Hosokawa M, Oshima K, Niizato K, Shiraishi A, Akiyama H, Mizusawa H.

Psychogeriatrics. 2018 Jul;18(4):307-312. doi: 10.1111/psyg.12334.

PMID:
30133939
8.

Progressive Encephalomyelitis with Rigidity and Myoclonus Resolving after Thymectomy with Subsequent Anasarca: An Autopsy Case.

Ozaki K, Ohkubo T, Yamada T, Yoshioka K, Ichijo M, Majima T, Kudo S, Akashi T, Honda K, Ito E, Watanabe M, Sekine M, Hamagaki M, Eishi Y, Sanjo N, Ishibashi S, Mizusawa H, Yokota T.

Intern Med. 2018 Dec 1;57(23):3451-3458. doi: 10.2169/internalmedicine.1238-18. Epub 2018 Jul 6.

9.

Tandem internal models execute motor learning in the cerebellum.

Honda T, Nagao S, Hashimoto Y, Ishikawa K, Yokota T, Mizusawa H, Ito M.

Proc Natl Acad Sci U S A. 2018 Jul 10;115(28):7428-7433. doi: 10.1073/pnas.1716489115. Epub 2018 Jun 25.

10.

Iatrogenic Creutzfeldt-Jakob disease.

Kobayashi A, Kitamoto T, Mizusawa H.

Handb Clin Neurol. 2018;153:207-218. doi: 10.1016/B978-0-444-63945-5.00012-X.

PMID:
29887137
11.

Analysis of risk factors for mild cognitive impairment based on word list memory test results and questionnaire responses in healthy Japanese individuals registered in an online database.

Ogawa M, Sone D, Maruo K, Shimada H, Suzuki K, Watanabe H, Matsuda H, Mizusawa H.

PLoS One. 2018 May 17;13(5):e0197466. doi: 10.1371/journal.pone.0197466. eCollection 2018.

12.

A diagnostic decision tree for adult cerebellar ataxia based on pontine magnetic resonance imaging.

Higashi M, Ozaki K, Hattori T, Ishii T, Soga K, Sato N, Tomita M, Mizusawa H, Ishikawa K, Yokota T.

J Neurol Sci. 2018 Apr 15;387:187-195. doi: 10.1016/j.jns.2018.02.022. Epub 2018 Feb 12.

PMID:
29571861
13.

Update: Dura Mater Graft-Associated Creutzfeldt-Jakob Disease - Japan, 1975-2017.

Ae R, Hamaguchi T, Nakamura Y, Yamada M, Tsukamoto T, Mizusawa H, Belay ED, Schonberger LB.

MMWR Morb Mortal Wkly Rep. 2018 Mar 9;67(9):274-278. doi: 10.15585/mmwr.mm6709a3. Erratum in: MMWR Morb Mortal Wkly Rep. 2018 Mar 30;67(12):373.

14.

Comprehensive systematic review summary: Treatment of cerebellar motor dysfunction and ataxia: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.

Zesiewicz TA, Wilmot G, Kuo SH, Perlman S, Greenstein PE, Ying SH, Ashizawa T, Subramony SH, Schmahmann JD, Figueroa KP, Mizusawa H, Schöls L, Shaw JD, Dubinsky RM, Armstrong MJ, Gronseth GS, Sullivan KL.

Neurology. 2018 Mar 6;90(10):464-471. doi: 10.1212/WNL.0000000000005055. Epub 2018 Feb 9.

15.

Biochemical features of genetic Creutzfeldt-Jakob disease with valine-to-isoleucine substitution at codon 180 on the prion protein gene.

Ito Y, Sanjo N, Hizume M, Kobayashi A, Ohgami T, Satoh K, Hamaguchi T, Yamada M, Kitamoto T, Mizusawa H, Yokota T.

Biochem Biophys Res Commun. 2018 Feb 19;496(4):1055-1061. doi: 10.1016/j.bbrc.2018.01.119. Epub 2018 Jan 31.

PMID:
29382530
16.

Idiopathic cerebellar ataxia (IDCA): Diagnostic criteria and clinical analyses of 63 Japanese patients.

Yoshida K, Kuwabara S, Nakamura K, Abe R, Matsushima A, Beppu M, Yamanaka Y, Takahashi Y, Sasaki H, Mizusawa H; Research Group on Ataxic Disorders.

J Neurol Sci. 2018 Jan 15;384:30-35. doi: 10.1016/j.jns.2017.11.008. Epub 2017 Nov 7.

17.

Sequence configuration of spinocerebellar ataxia type 8 repeat expansions in a Japanese cohort of 797 ataxia subjects.

Hu Y, Hashimoto Y, Ishii T, Rayle M, Soga K, Sato N, Okita M, Higashi M, Ozaki K, Mizusawa H, Ishikawa K, Yokota T.

J Neurol Sci. 2017 Nov 15;382:87-90. doi: 10.1016/j.jns.2017.08.3256. Epub 2017 Aug 31.

PMID:
29111027
18.

The professional practice and training of neurology in the Asian and Oceanian Region: A cross-sectional survey by the Asian and Oceanian Association of Neurology (AOAN).

Roxas A Jr, Mehndiratta MM, Bornstein N, Macdonell R, Lim KS, Ng PW, Dashzeveg S, Mizusawa H, Esmatullah H, Wu SL, Chen C, Kurniawan M, Rha JH, Wasay M, Poungvarin N, Gunatilake S, Thang NH.

J Neurol Sci. 2017 Nov 15;382:108-115. doi: 10.1016/j.jns.2017.09.022. Epub 2017 Sep 20.

PMID:
29111001
19.

Glycaemic control boosts glucosylated nanocarrier crossing the BBB into the brain.

Anraku Y, Kuwahara H, Fukusato Y, Mizoguchi A, Ishii T, Nitta K, Matsumoto Y, Toh K, Miyata K, Uchida S, Nishina K, Osada K, Itaka K, Nishiyama N, Mizusawa H, Yamasoba T, Yokota T, Kataoka K.

Nat Commun. 2017 Oct 17;8(1):1001. doi: 10.1038/s41467-017-00952-3.

20.

Re-evaluation of soluble APP-α and APP-β in cerebrospinal fluid as potential biomarkers for early diagnosis of dementia disorders.

Araki W, Hattori K, Kanemaru K, Yokoi Y, Omachi Y, Takano H, Sakata M, Yoshida S, Tsukamoto T, Murata M, Saito Y, Kunugi H, Goto YI, Nagaoka U, Nagao M, Komori T, Arima K, Ishii K, Murayama S, Matsuda H, Tachimori H, Araki YM, Mizusawa H.

Biomark Res. 2017 Sep 22;5:28. doi: 10.1186/s40364-017-0108-5. eCollection 2017.

21.

Subacute Supranuclear Palsy in anti-Hu Paraneoplastic Encephalitis.

Ohyagi M, Ishibashi S, Ohkubo T, Kobayashi Z, Mizusawa H, Yokota T, Emoto H, Kiyosawa M.

Can J Neurol Sci. 2017 Jul;44(4):444-446. doi: 10.1017/cjn.2016.430. No abstract available.

PMID:
28767032
22.

Long-term Effects of Intravenous Cyclophosphamide in Combination with Mesna Provided Intravenously and via Bladder Perfusion in a Patient with Severe Multifocal Motor Neuropathy.

Iwasawa E, Ohkubo T, Kanouchi T, Kanda T, Mizusawa H, Yokota T.

Intern Med. 2017;56(14):1893-1896. doi: 10.2169/internalmedicine.56.8157. Epub 2017 Jul 15.

23.

Questionnaire survey on the process of specialty training in neurology in Japan.

Sonoo M, Nishiyama K, Ando T, Shindo K, Kanda T, Aoki M, Kamei S, Kikuchi S, Kusunoki S, Suzuki N, Sobue G, Nakashima K, Hara H, Hirata K, Mizusawa H, Murai H, Murata M, Mochizuki H, Takahashi R, Kira JI.

Rinsho Shinkeigaku. 2017 Jul 29;57(7):402-410. doi: 10.5692/clinicalneurol.cn-001061. Epub 2017 Jul 21. Japanese.

PMID:
28637938
24.

Alternative splicing in the C-terminal tail of Cav2.1 is essential for preventing a neurological disease in mice.

Aikawa T, Watanabe T, Miyazaki T, Mikuni T, Wakamori M, Sakurai M, Aizawa H, Ishizu N, Watanabe M, Kano M, Mizusawa H, Watase K.

Hum Mol Genet. 2017 Aug 15;26(16):3094-3104. doi: 10.1093/hmg/ddx193.

PMID:
28510727
25.

Regulatory Role of RNA Chaperone TDP-43 for RNA Misfolding and Repeat-Associated Translation in SCA31.

Ishiguro T, Sato N, Ueyama M, Fujikake N, Sellier C, Kanegami A, Tokuda E, Zamiri B, Gall-Duncan T, Mirceta M, Furukawa Y, Yokota T, Wada K, Taylor JP, Pearson CE, Charlet-Berguerand N, Mizusawa H, Nagai Y, Ishikawa K.

Neuron. 2017 Apr 5;94(1):108-124.e7. doi: 10.1016/j.neuron.2017.02.046. Epub 2017 Mar 23.

26.

Structural connectivity in spatial attention network: reconstruction from left hemispatial neglect.

Hattori T, Ito K, Nakazawa C, Numasawa Y, Watanabe M, Aoki S, Mizusawa H, Ishiai S, Yokota T.

Brain Imaging Behav. 2018 Apr;12(2):309-323. doi: 10.1007/s11682-017-9698-7.

PMID:
28290071
27.

Depressive disorder may be associated with raphe nuclei lesions in patients with brainstem infarction.

Numasawa Y, Hattori T, Ishiai S, Kobayashi Z, Kamata T, Kotera M, Ishibashi S, Sanjo N, Mizusawa H, Yokota T.

J Affect Disord. 2017 Apr 15;213:191-198. doi: 10.1016/j.jad.2017.02.005. Epub 2017 Feb 7.

PMID:
28278447
28.

Impaired striatal dopamine release in homozygous Vps35 D620N knock-in mice.

Ishizu N, Yui D, Hebisawa A, Aizawa H, Cui W, Fujita Y, Hashimoto K, Ajioka I, Mizusawa H, Yokota T, Watase K.

Hum Mol Genet. 2016 Oct 15;25(20):4507-4517. doi: 10.1093/hmg/ddw279.

PMID:
28173004
29.

Gene dosage effect in spinocerebellar ataxia type 6 homozygotes: A clinical and neuropathological study.

Soga K, Ishikawa K, Furuya T, Iida T, Yamada T, Ando N, Ota K, Kanno-Okada H, Tanaka S, Shintaku M, Eishi Y, Mizusawa H, Yokota T.

J Neurol Sci. 2017 Feb 15;373:321-328. doi: 10.1016/j.jns.2016.12.051. Epub 2016 Dec 27.

PMID:
28131213
30.

Thalamic involvement determined using VSRAD advance on MRI and easy Z-score analysis of 99mTc-ECD-SPECT in Gerstmann-Sträussler-Scheinker syndrome with P102L mutation.

Sugiyama A, Sato N, Kimura Y, Maekawa T, Wakasugi N, Sone D, Enokizono M, Takahashi Y, Murata M, Mizusawa H, Matsuda H.

J Neurol Sci. 2017 Feb 15;373:27-30. doi: 10.1016/j.jns.2016.12.021. Epub 2016 Dec 15.

PMID:
28131204
31.

Processes of anticipatory postural adjustment and step movement of gait initiation.

Mizusawa H, Jono Y, Iwata Y, Kinoshita A, Hiraoka K.

Hum Mov Sci. 2017 Apr;52:1-16. doi: 10.1016/j.humov.2017.01.003. Epub 2017 Jan 13.

PMID:
28088660
32.

Interhemispheric Inhibition Induced by Transcranial Magnetic Stimulation Over Primary Sensory Cortex.

Iwata Y, Jono Y, Mizusawa H, Kinoshita A, Hiraoka K.

Front Hum Neurosci. 2016 Aug 31;10:438. doi: 10.3389/fnhum.2016.00438. eCollection 2016.

33.

PRION 2016 Tokyo Declaration.

Mizusawa H, Kuwata K.

Prion. 2016 Jul 3;10(4):265-6. doi: 10.1080/19336896.2016.1220242. No abstract available.

34.

[Bilateral Testicular Tumor after Bilateral Orchiopexy : A Case Report].

Saito T, Mizusawa H, Hara H, Domen T.

Hinyokika Kiyo. 2016 May;62(5):279-81. Japanese.

PMID:
27320122
35.

Significant association of cadaveric dura mater grafting with subpial Aβ deposition and meningeal amyloid angiopathy.

Hamaguchi T, Taniguchi Y, Sakai K, Kitamoto T, Takao M, Murayama S, Iwasaki Y, Yoshida M, Shimizu H, Kakita A, Takahashi H, Suzuki H, Naiki H, Sanjo N, Mizusawa H, Yamada M.

Acta Neuropathol. 2016 Aug;132(2):313-5. doi: 10.1007/s00401-016-1588-3. Epub 2016 Jun 17. No abstract available.

PMID:
27314593
36.

ORANGE's challenge: developing wide-ranging dementia research in Japan.

Saji N, Sakurai T, Suzuki K, Mizusawa H, Toba K; ORANGE investigators.

Lancet Neurol. 2016 Jun;15(7):661-662. doi: 10.1016/S1474-4422(16)30009-6. Epub 2016 May 9. No abstract available.

PMID:
27302232
37.

Progressive Multifocal Leukoencephalopathy with Balanced CD4/CD8 T-Cell Infiltration and Good Response to Mefloquine Treatment.

Sanjo N, Kina S, Shishido-Hara Y, Nose Y, Ishibashi S, Fukuda T, Maehara T, Eishi Y, Mizusawa H, Yokota T.

Intern Med. 2016;55(12):1631-5. doi: 10.2169/internalmedicine.55.6051. Epub 2016 Jun 15.

38.
39.

Specific clinical signs and symptoms are predictive of clinical course in sporadic Creutzfeldt-Jakob disease.

Nakatani E, Kanatani Y, Kaneda H, Nagai Y, Teramukai S, Nishimura T, Zhou B, Kojima S, Kono H, Fukushima M, Kitamoto T, Mizusawa H.

Eur J Neurol. 2016 Sep;23(9):1455-62. doi: 10.1111/ene.13057. Epub 2016 May 24.

40.

Multiple sclerosis and neuromyelitis optica spectrum disorders: some similarities in two distinct diseases.

Yokote H, Mizusawa H.

Neural Regen Res. 2016 Mar;11(3):410-1. doi: 10.4103/1673-5374.179048. No abstract available.

41.

Supplement Note.

Mizusawa H.

Prion. 2016;10 Suppl 1:S1. doi: 10.1080/19336896.2016.1173501. No abstract available.

PMID:
27088806
42.

Prevalence of Autoantibodies and the Efficacy of Immunotherapy for Autoimmune Cerebellar Ataxia.

Nanri K, Okuma M, Sato S, Yoneda M, Taguchi T, Mitoma H, Yamada J, Unezaki S, Nagatani T, Otsubo S, Sugawara M, Tanaka N, Mizusawa H.

Intern Med. 2016;55(5):449-54. doi: 10.2169/internalmedicine.55.5156. Epub 2016 Mar 1.

43.

Quantifying prion disease penetrance using large population control cohorts.

Minikel EV, Vallabh SM, Lek M, Estrada K, Samocha KE, Sathirapongsasuti JF, McLean CY, Tung JY, Yu LP, Gambetti P, Blevins J, Zhang S, Cohen Y, Chen W, Yamada M, Hamaguchi T, Sanjo N, Mizusawa H, Nakamura Y, Kitamoto T, Collins SJ, Boyd A, Will RG, Knight R, Ponto C, Zerr I, Kraus TF, Eigenbrod S, Giese A, Calero M, de Pedro-Cuesta J, Haïk S, Laplanche JL, Bouaziz-Amar E, Brandel JP, Capellari S, Parchi P, Poleggi A, Ladogana A, O'Donnell-Luria AH, Karczewski KJ, Marshall JL, Boehnke M, Laakso M, Mohlke KL, Kähler A, Chambert K, McCarroll S, Sullivan PF, Hultman CM, Purcell SM, Sklar P, van der Lee SJ, Rozemuller A, Jansen C, Hofman A, Kraaij R, van Rooij JG, Ikram MA, Uitterlinden AG, van Duijn CM; Exome Aggregation Consortium (ExAC), Daly MJ, MacArthur DG.

Sci Transl Med. 2016 Jan 20;8(322):322ra9. doi: 10.1126/scitranslmed.aad5169.

44.

Enhanced Phospholipase A2 Group 3 Expression by Oxidative Stress Decreases the Insulin-Degrading Enzyme.

Yui D, Nishida Y, Nishina T, Mogushi K, Tajiri M, Ishibashi S, Ajioka I, Ishikawa K, Mizusawa H, Murayama S, Yokota T.

PLoS One. 2015 Dec 4;10(12):e0143518. doi: 10.1371/journal.pone.0143518. eCollection 2015.

45.

Enteral siRNA delivery technique for therapeutic gene silencing in the liver via the lymphatic route.

Murakami M, Nishina K, Watanabe C, Yoshida-Tanaka K, Piao W, Kuwahara H, Horikiri Y, Miyata K, Nishiyama N, Kataoka K, Yoshida M, Mizusawa H, Yokota T.

Sci Rep. 2015 Nov 23;5:17035. doi: 10.1038/srep17035.

46.

Efficacy of intravenous methylprednisolone pulse therapy in patients with multiple sclerosis and neuromyelitis optica.

Yamasaki R, Matsushita T, Fukazawa T, Yokoyama K, Fujihara K, Ogino M, Yokota T, Miyamoto K, Niino M, Nomura K, Tomioka R, Tanaka M, Kawachi I, Ohashi T, Kaida K, Matsui M, Nakatsuji Y, Ochi H, Fukaura H, Kanda T, Nagaishi A, Togo K, Mizusawa H, Murai H, Kira J.

Mult Scler. 2016 Sep;22(10):1337-48. doi: 10.1177/1352458515617248. Epub 2015 Nov 12.

PMID:
26564994
47.

Clinical, biochemical and molecular investigation of adult-onset glutaric acidemia type II: Characteristics in comparison with pediatric cases.

Yamada K, Kobayashi H, Bo R, Takahashi T, Purevsuren J, Hasegawa Y, Taketani T, Fukuda S, Ohkubo T, Yokota T, Watanabe M, Tsunemi T, Mizusawa H, Takuma H, Shioya A, Ishii A, Tamaoka A, Shigematsu Y, Sugie H, Yamaguchi S.

Brain Dev. 2016 Mar;38(3):293-301. doi: 10.1016/j.braindev.2015.08.011. Epub 2015 Sep 26.

PMID:
26403312
48.

Sphingosine-1-Phosphate Receptor-1 Selective Agonist Enhances Collateral Growth and Protects against Subsequent Stroke.

Ichijo M, Ishibashi S, Li F, Yui D, Miki K, Mizusawa H, Yokota T.

PLoS One. 2015 Sep 14;10(9):e0138029. doi: 10.1371/journal.pone.0138029. eCollection 2015.

49.
50.

DNA/RNA heteroduplex oligonucleotide for highly efficient gene silencing.

Nishina K, Piao W, Yoshida-Tanaka K, Sujino Y, Nishina T, Yamamoto T, Nitta K, Yoshioka K, Kuwahara H, Yasuhara H, Baba T, Ono F, Miyata K, Miyake K, Seth PP, Low A, Yoshida M, Bennett CF, Kataoka K, Mizusawa H, Obika S, Yokota T.

Nat Commun. 2015 Aug 10;6:7969. doi: 10.1038/ncomms8969.

Supplemental Content

Loading ...
Support Center